Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>cas 24666-56-6 Lenalidomide Intermediate 2,6-Dioxopiperidine-3-ammonium chloride powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

cas 24666-56-6 Lenalidomide Intermediate 2,6-Dioxopiperidine-3-ammonium chloride powder

CAS NO.24666-56-6

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Lenalidomide Intermediate
  • Lenalidomide Intermediate powder
  • 99% Lenalidomide Intermediate

Quick Details

  • ProName: cas 24666-56-6 Lenalidomide Intermed...
  • CasNo: 24666-56-6
  • Molecular Formula: C15H22O5
  • Appearance: white
  • Application: API intermediate
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Month
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

cas  24666-56-6  Lenalidomide Intermediate  2,6-Dioxopiperidine-3-ammonium chloride powder

Product Name:    2,6-Dioxopiperidine-3-ammonium chloride
CAS:    24666-56-6
MF:    C5H9ClN2O2
MW:    164.59016
EINECS:    807-866-6

 

Details

cas  24666-56-6  Lenalidomide Intermediate  2,6-Dioxopiperidine-3-ammonium chloride powder

Product Name:    2,6-Dioxopiperidine-3-ammonium chloride
CAS:    24666-56-6
MF:    C5H9ClN2O2
MW:    164.59016
EINECS:    807-866-6

API intermediate  

2,6-Dioxopiperidine-3-ammonium chloride is a reagent for preparing lenalidomide that can induce ubiquitination and degradation of CK1α in del (5q) MDS. It can also be used to prepare phthalimide conjugates that can promote ligand-dependent target protein degradation. Moreover, it is also a metabolite of thalidomide  that inhibits FGF-induced angiogenesis.